These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 25930117)
21. Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions. Kurokawa M; Sato S J Biosci Bioeng; 2011 May; 111(5):600-4. PubMed ID: 21262586 [TBL] [Abstract][Full Text] [Related]
22. Rabies virus production in high vero cell density cultures on macroporous microcarriers. Yokomizo AY; Antoniazzi MM; Galdino PL; Azambuja N; Jorge SA; Pereira CA Biotechnol Bioeng; 2004 Mar; 85(5):506-15. PubMed ID: 14760691 [TBL] [Abstract][Full Text] [Related]
23. Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells. Nikolay A; Castilho LR; Reichl U; Genzel Y Vaccine; 2018 May; 36(22):3140-3145. PubMed ID: 28343780 [TBL] [Abstract][Full Text] [Related]
24. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium. Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647 [TBL] [Abstract][Full Text] [Related]
25. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus. Wu SC; Huang GY Biotechnol Prog; 2002; 18(1):124-8. PubMed ID: 11822910 [TBL] [Abstract][Full Text] [Related]
26. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask. Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056 [TBL] [Abstract][Full Text] [Related]
27. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733 [TBL] [Abstract][Full Text] [Related]
28. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium. He C; Yang Z; Tong K J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872 [TBL] [Abstract][Full Text] [Related]
29. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity. Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837 [TBL] [Abstract][Full Text] [Related]
30. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311 [TBL] [Abstract][Full Text] [Related]
31. Development of suspension adapted Vero cell culture process technology for production of viral vaccines. Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997 [TBL] [Abstract][Full Text] [Related]
32. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines. Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007 [TBL] [Abstract][Full Text] [Related]
33. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density. Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175 [TBL] [Abstract][Full Text] [Related]
34. Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture. Pato TP; Souza MCO; Mattos DA; Caride E; Ferreira DF; Gaspar LP; Freire MS; Castilho LR Vaccine; 2019 May; 37(24):3214-3220. PubMed ID: 31047674 [TBL] [Abstract][Full Text] [Related]
35. Large-scale Vero cell culture on microcarriers in a twenty-liter stirred tank fermentor. Liau MY; Hsiun DY; Li SY; Horng CB; Wu SC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 Aug; 29(3):143-52. PubMed ID: 10592796 [TBL] [Abstract][Full Text] [Related]
36. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor. Trabelsi K; Majoul S; Rourou S; Kallel H Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589 [TBL] [Abstract][Full Text] [Related]
37. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Berry JM; Barnabé N; Coombs KM; Butler M Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508 [TBL] [Abstract][Full Text] [Related]
38. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters. Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746 [TBL] [Abstract][Full Text] [Related]
39. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture. Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636 [TBL] [Abstract][Full Text] [Related]
40. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells. Conceição MM; Tonso A; Freitas CB; Pereira CA Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]